Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.050
+0.098 (5.02%)
At close: Jun 27, 2025, 4:00 PM
1.991
-0.059 (-2.88%)
After-hours: Jun 27, 2025, 4:06 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $14.40 million as of June 27, 2025. Its market cap has increased by 0.67% in one year.
Market Cap
14.40M
Enterprise Value
499.84K
1-Year Change
0.67%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $14.40M, a decrease of -80.78%. That is a compound annual growth rate of -15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 14.40M | 148.28% |
| Dec 31, 2024 | 5.80M | -60.00% |
| Dec 29, 2023 | 14.50M | -65.31% |
| Dec 30, 2022 | 41.80M | -45.07% |
| Dec 31, 2021 | 76.10M | 70.25% |
| Dec 31, 2020 | 44.70M | 45.13% |
| Dec 31, 2019 | 30.80M | 528.57% |
| Dec 31, 2018 | 4.90M | -42.35% |
| Dec 29, 2017 | 8.50M | -58.74% |
| Dec 30, 2016 | 20.60M | -62.34% |
| Dec 31, 2015 | 54.70M | -26.97% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.18B |
| Johnson & Johnson | 366.85B |
| AbbVie | 329.52B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 277.71B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.68B |
| AstraZeneca | 215.99B |